Vendor profile
AMGEN BIOFARMACEUTICA, LDA
PT- Awards
- 17
- Total awarded value
- €354,843,544
- Countries
- countries.PT
- Latest award
- May 12, 2026
- Expiring within 12 months
- 0
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 05/12/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta | — | €396.6K | PT | — | View on TED ↗ |
| 03/19/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES | — | €633.2K | PT | — | View on TED ↗ |
| 10/21/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] | — | €416.3K | PT | — | View on TED ↗ |
| 08/12/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the musculo-skeletal system – 2024/0780 - DENOSUMAB [120 MG; SOL INJ; FRS] | — | €262.0K | PT | — | View on TED ↗ |
| 08/12/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the musculo-skeletal system – 2024/0780 - DENOSUMAB [120 MG; SOL INJ; FRS] | — | €52.4K | PT | — | View on TED ↗ |
| 07/15/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - ROMIPLOSTIM [250 µG; PÓ SOL INJ; F/AMP] | — | €68.9K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | €89.6K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491-CARFILZOMIB [60 MG; PÓ SOL INJ; FRS] (C23135) | — | €750.0K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491-CARFILZOMIB [60 MG; PÓ SOL INJ; FRS] (C23135) | — | €745.5K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | €931.8K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | €188.2K | PT | — | View on TED ↗ |
| 04/02/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000717 - ADALIMUMAB 40 MG/0,4 ML SOL INJ BIOSSIMILAR CANETA ( AMGEVITA ) | — | €292.3K | PT | — | View on TED ↗ |
| 12/03/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue | — | €308.5K | PT | — | View on TED ↗ |
| 10/23/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (B707) | — | €42.2K | PT | — | View on TED ↗ |
| 10/22/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (P749) | — | €37.7K | PT | — | View on TED ↗ |
| 10/22/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (P749) | — | €188.3K | PT | — | View on TED ↗ |
| 04/16/2024 | Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM) | Portugal – Various medicinal products – ECULIZUMAB | — | €349.4M | PT | — | View on TED ↗ |